UTL is a private company manufacturing and marketing ultrasound-based equipment for therapeutic applications. Currently UTL is carrying out clinical trials on cancer therapies at the Churchill Hospital, Oxford, using HAIFU equipment manufactured by Chongqing (HAIFU) HIFU Technology Co. Ltd., for which UTL has the sole distribution rights in the West.
The HAIFU System being used at Oxford is one of over 30 units (mainly installed in the Far East) and over 8,000 patients have been treated. The advanced patented HAIFU System offers the only high intensity ultrasound therapy for the treatment of solid tumours, in a variety of organs, that is commercially available. This device has recently gained universal CE Mark approval for clinical use and is available for private treatment of cancers in the kidneys, liver, pancreas and bone. [read more ...]
